share_log

Cingulate | 4: Statement of changes in beneficial ownership of securities-Officer Brams Matthew

Cingulate | 4: Statement of changes in beneficial ownership of securities

Cingulate | 4：持股变动声明
SEC announcement ·  04/02 07:03
牛牛AI助手已提取核心信息
Matthew Brams, EVP and Chief Medical Officer of Cingulate Inc. [CING], was involved in a transaction on 03/29/2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and total value of shares, were not disclosed in the announcement. The action type and status, as well as the number of shares held after the action, were also not provided. Investors are advised to seek additional information to fully understand the impact of this event on their investment decisions.
Matthew Brams, EVP and Chief Medical Officer of Cingulate Inc. [CING], was involved in a transaction on 03/29/2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and total value of shares, were not disclosed in the announcement. The action type and status, as well as the number of shares held after the action, were also not provided. Investors are advised to seek additional information to fully understand the impact of this event on their investment decisions.
Cingulate Inc. [CING] 执行副总裁兼首席医学官马修·布拉姆斯于2024年3月29日参与了一笔交易。公告中未披露该交易的具体细节，包括股票数量、股票性质、交易价格和股票总价值。也没有提供行动类型和状态以及行动后持有的股票数量。建议投资者寻求更多信息，以充分了解这一事件对其投资决策的影响。
Cingulate Inc. [CING] 执行副总裁兼首席医学官马修·布拉姆斯于2024年3月29日参与了一笔交易。公告中未披露该交易的具体细节，包括股票数量、股票性质、交易价格和股票总价值。也没有提供行动类型和状态以及行动后持有的股票数量。建议投资者寻求更多信息，以充分了解这一事件对其投资决策的影响。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

译文内容由第三方软件翻译。


牛牛AI助手部分由第三方人工智能模型基于资讯内容自动生成，只对中国内地以外的地区提供。


以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。